You are here

Jazz Pharma

Jazz halts sleep disorder med trial over 'visual disturbances' and CV effects

Jazz halts sleep disorder med trial over 'visual disturbances' and CV effects

Fierce Biotech

phase 1 sleep disorder

Sumitomo Pharma

Flag link:

Autifony swings $770.5m deal with Jazz for CNS drugs

Autifony swings $770.5m deal with Jazz for CNS drugs

Pharmaphorum

neurological disorders

Flag link:

Jazz looks at strategic options, including possible sale or unit divestiture

Jazz looks at strategic options, including possible sale or unit divestiture

Fierce Pharma

Flag link:

6 Drugs Approved Despite Failed Trials or Minimal Data

6 Drugs Approved Despite Failed Trials or Minimal Data

BioSpace

Sarepta Therapeutics

Flag link:

Jazz Pharma sues FDA over approval of rival narcolepsy drug

Jazz Pharma sues FDA over approval of rival narcolepsy drug

Medical Marketing and Media

Flag link:

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

With FDA nod for Lumryz, Avadel is set to Jazz up the narcolepsy market

Fierce Pharma

Flag link:

Jazz loses appeal, will have patent delisted from the Orange Book

Jazz loses appeal, will have patent delisted from the Orange Book

Endpoints

Flag link:

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Fierce Pharma

Flag link:

Jazz hands Zymeworks a much-needed win for biliary tract cancer drug after peek at data

Jazz hands Zymeworks a much-needed win for biliary tract cancer drug after peek at data

Fierce Biotech

biliary tract cancer

Flag link:

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Federal Circuit court halts delisting of Jazz narcolepsy drug patent from the Orange Book

Endpoints

Flag link:

PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex

PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex

Fierce Pharma

PureTech Health

Flag link:

In Jazz case, FTC urges court to delist patent on blockbuster Xyrem

In Jazz case, FTC urges court to delist patent on blockbuster Xyrem

Fierce Pharma

Flag link:

Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial

Jazz Takes Groundbreaking Epilepsy Drug into Kids in Phase III Trial

BioSpace

clinical trials

Flag link:

Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug

Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug

Fierce Pharma

Flag link:

Jazz’s toehold on sleep market slips with tentative Avadel FDA approval

Jazz’s toehold on sleep market slips with tentative Avadel FDA approval

BioSpace

excessive daytime sleepiness

sleep disorders

Flag link:

Trial failure for Jazz’s cannabis-derived drug blunts goal to expand its use to US

Trial failure for Jazz’s cannabis-derived drug blunts goal to expand its use to US

Fierce Pharma

Flag link:

Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders

Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders

Bio Spectrum Asia

Sumitomo Pharma

sleep disorders

Flag link:

Jazz Pharma Announces $100 Million “Green” Manufacturing Plant for Cannabis-Based Medicines

Jazz Pharma Announces $100 Million “Green” Manufacturing Plant for Cannabis-Based Medicines

Xtalks

drug manufacturing

Flag link:

Once heralded as its next big cash cow, Jazz takes a marked down price for not-so-hot sleep disorder drug

Once heralded as its next big cash cow, Jazz takes a marked down price for not-so-hot sleep disorder drug

Endpoints

Axsome Therapeutics

Flag link:

UCB takes on Jazz in severe epilepsy with new Fintepla approval

UCB takes on Jazz in severe epilepsy with new Fintepla approval

Pharmaforum

Lennox-Gastaut Syndrome

Flag link:

Pages